股票/基金 实时行情 股吧

简称:汉森制药 代码:002412


会计年度:2011-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药制造业400,680,700.0096,151,000.00304,529,700.0076.00

会计年度:2011-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
八支装四磨汤口服液70,305,500.0013,489,900.0056,815,600.0080.81
六支装四磨汤口服液4,914,200.00944,800.003,969,400.0080.77
其他14,086,100.0011,253,300.002,832,800.0020.11
其中:固体口服制剂6,233,800.004,231,400.002,002,400.0032.12
其中:液体口服制剂1,231,000.001,267,400.00-36,400.00-2.96
其中:注射剂6,621,200.005,754,600.00866,600.0013.09
十支装四磨汤口服液48,376,900.009,161,800.0039,215,100.0081.06
缩泉胶囊14,102,000.002,227,800.0011,874,200.0084.20
银杏叶胶囊14,244,100.003,192,600.0011,051,500.0077.59
愈伤灵胶囊9,671,700.002,480,600.007,191,100.0074.35

会计年度:2010-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
十支装四磨汤口服液91,825,469.9017,150,051.02----
10.注射剂12,636,362.0910,466,664.73----
1合计343,414,849.2980,658,713.31----
八支装四磨汤口服液141,182,497.6726,898,115.31----
六支装四磨汤口服液7,617,732.971,527,015.63----
愈伤灵胶囊25,734,561.645,698,718.85----
银杏叶胶囊23,588,181.645,202,060.24----
6.缩泉胶囊26,400,173.893,518,862.46----
7.其他27,066,231.5820,663,889.80----
8.其中:固体口服制剂12,451,248.058,217,699.21----
9.液体口服制剂1,978,621.441,979,525.86----
八支装四磨汤口服液141,182,497.6726,898,115.31114,284,382.36--
固体口服制剂12,451,248.058,217,699.214,233,548.84--
六支装四磨汤口服液7,617,732.971,527,015.636,090,717.34--
十支装四磨汤口服液91,825,469.9017,150,051.0274,675,418.88--
缩泉胶囊26,400,173.893,518,862.4622,881,311.43--
液体口服制剂1,978,621.441,979,525.86-904.42--
银杏叶胶囊23,588,181.645,202,060.2418,386,121.40--
愈伤灵胶囊25,734,561.645,698,718.8520,035,842.79--
注射剂12,636,362.0910,466,664.732,169,697.36--

会计年度:2010-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
八支装四磨汤口服液59,099,500.0011,383,000.0047,716,500.0080.74
六支装四磨汤口服液3,944,400.00797,400.003,147,000.0079.78
其他24,960,400.0011,973,100.0012,987,300.0052.03
其中:固体口服制剂18,004,800.006,073,000.0011,931,800.0066.27
其中:液体口服制剂1,357,400.001,367,500.00-10,100.00-0.74
其中:注射剂5,598,200.004,532,600.001,065,600.0019.03
十支装四磨汤口服液41,394,200.007,748,300.0033,645,900.0081.28
银杏叶胶囊10,118,100.002,251,000.007,867,100.0077.75
愈伤灵胶囊11,668,500.002,095,600.009,572,900.0082.04

    5/5 转到